08158.HK
China Regenerative Medicine International Limited
HKSE · Healthcare · Biotechnology · HK
HKD 0.25
−0.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.49x
- PEG TTM
- 0.03x
- Price / book
- 1.31x
- Price / sales
- 0.70x
- Price / cash flow
- 4.77x
Enterprise value
- Enterprise value
- HKD 111.0M
- EV / sales
- 1.03x
- EV / EBITDA
- 4.45x
- EV / EBIT
- 2.43x
- Market cap
- HKD 74.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026